SE324160B - - Google Patents

Info

Publication number
SE324160B
SE324160B SE1821/65A SE182165A SE324160B SE 324160 B SE324160 B SE 324160B SE 1821/65 A SE1821/65 A SE 1821/65A SE 182165 A SE182165 A SE 182165A SE 324160 B SE324160 B SE 324160B
Authority
SE
Sweden
Application number
SE1821/65A
Inventor
J Augstein
A Monro
G Potter
T Wrigley
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE324160B publication Critical patent/SE324160B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE1821/65A 1964-02-14 1965-02-12 SE324160B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6225/64A GB1023796A (en) 1964-02-14 1964-02-14 Guanidino compounds

Publications (1)

Publication Number Publication Date
SE324160B true SE324160B (fr) 1970-05-25

Family

ID=9810688

Family Applications (1)

Application Number Title Priority Date Filing Date
SE1821/65A SE324160B (fr) 1964-02-14 1965-02-12

Country Status (7)

Country Link
US (1) US3306913A (fr)
BE (1) BE659663A (fr)
BR (1) BR6567082D0 (fr)
CH (1) CH451194A (fr)
FR (1) FR4600M (fr)
GB (1) GB1023796A (fr)
SE (1) SE324160B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882147A (en) * 1969-06-09 1975-05-06 Merck & Co Inc 3-Hydroxy-3-(3,4-methylenedioxyphenylalkyl-3,4-dihydro-2H-1,5-benzodioxepin products
US3700691A (en) * 1969-06-09 1972-10-24 Frosst & Co Charles E 3,3-disubstituted-3,4-dihydrobenzodioxepins
US3907793A (en) * 1972-05-01 1975-09-23 Merck & Co Inc 3-Hydroxy-3-morpholino-loweralkyl-3,4-dihydro-2H-1,5-benzodioxepin products
US4234598A (en) * 1979-04-11 1980-11-18 Hoffmann-La Roche Inc. Phenylcarbamates
US4423063A (en) * 1980-12-29 1983-12-27 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis
DK166779B1 (da) * 1983-12-14 1993-07-12 Takeda Chemical Industries Ltd 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse
US4736031A (en) * 1985-06-10 1988-04-05 Takeda Chemical Industries, Ltd. 2-(piperazinylalkyl)-1-benzothiepin, 1-benzoxepin, and 1,5-benzodioxepin derivatives

Also Published As

Publication number Publication date
BE659663A (fr) 1965-08-12
CH451194A (de) 1968-05-15
GB1023796A (en) 1966-03-23
BR6567082D0 (pt) 1973-08-14
US3306913A (en) 1967-02-28
FR4600M (fr) 1966-11-21

Similar Documents

Publication Publication Date Title
FR4600M (fr)
BE642458A (fr)
BE626083A (fr)
BE661076A (fr)
BE660605A (fr)
BE660545A (fr)
BE660470A (fr)
BE660317A (fr)
BE659443A (fr)
BE658956A (fr)
BE658709A (fr)
BE658444A (fr)
BE655788A (fr)
BE655203A (fr)
BE654971A (fr)
BE653477A (fr)
BE650023A (fr)
BE643094A (fr)
BE643055A (fr)
BE642974A (fr)
BE642797A (fr)
BE642770A (fr)
BE642741A (fr)
BE642735A (fr)
BE642654A (fr)